The UK insurtech landscape: Strong, shifting, collaborative

| Article

The UK insurtech industry has seen persistent success despite cooling trends in global insurtech investment. Funding rounds in 2024 were up 8 percent compared with 2023,1 the first time funding has increased since 2021.2 This has powered companies with fresh solutions and innovative partnerships designed to tackle emerging risks. A growing number of players in the UK insurtech scene are set to expand internationally in the coming years.

To understand this dynamic insurtech hub, we launched our 2025 insurtech survey to see what’s changed since our 2023 report.3 One key finding stood out: Insurtech archetypes are shifting, moving from full-spectrum insurance entities4 to value chain enablers, which provide solutions at one or a few parts of the value chain. We also discovered other key findings, including information about the funding landscape, the rise of gen AI, increasing innovation in response to risks, and more.

This industry perspective provides an overview of the UK insurtech landscape using data from McKinsey and Insurtech UK’s 2025 survey, revealing trends defining the UK insurtech landscape today (see sidebar “About the research”). With this information, insurtech firms and entrepreneurs, industry incumbents, and investors can create informed future outlooks and strategies for the coming years.

The United Kingdom is a globally leading insurtech hub

Since 2019, the UK insurtech sector has attracted the second largest share of funding in the world after the United States, according to McKinsey analysis. Between 2022 and 2024, the United Kingdom secured about 5 percent of global insurtech funding, ahead of larger countries and emerging economies such as India and China, with a deal size that was consistently larger than any other European country. The United Kingdom is also home to the world’s fastest-growing pool of insurtech companies, with the number of insurtechs growing 7 percent since 2022, and the highest number of insurtechs per capita among major economies. This growth is coupled with stability: In the 2022–24 period, the ratio of newly founded insurance companies per total population in the United Kingdom was similar to that of other regions, but the United Kingdom had only half the exit rate (Exhibit 1).5

The United Kingdom is a global insurtech hub with the highest per-capita volume and the second largest share of global deals.
Image description: Grouped bar charts compare the 2022 and 2024 estimated numbers of insurtechs in the top 10 world economies per million people of the 2024 population. The United Kingdom tops the list, with 4.9 insurtechs per million people in 2022, and 5.2 in 2024. The United States has 3.6 in 2022 and 3.7 in 2024. Canada has 2.6 and 2.7. France has 1.6 and 1.7. Germany has 1.4 in both years. South Korea has 1.1 in both years. Italy has 0.7 and 0.6. Japan has 0.2 in both years. Finally, China and India both have 0.1 for 2022 and 2024. A callout says that in terms of global investment, the United Kingdom has a 5% share of cumulative deal value in the 2022–24 period. Note: Global investment includes only private equity and venture capital deals. Source: Dealroom; PitchBook; McKinsey analysis End image description

Since 2024, the United Kingdom has seen moderate acceleration in investment

Global investments in insurtechs, as a share of global insurance investments, peaked in 2020 and have declined since then. Although the United Kingdom was not immune to this trend,6 the UK insurtech industry experienced a moderate acceleration in investment in 2024, with an increase in the number of venture capital (VC) deals of approximately 8 percent compared to 2023. Since the COVID-19 pandemic, VC deals have been the main driver for UK insurtech, although the number of seed investments has been declining since 2021.7 This suggests that VCs are still cautious with new entrants in the market. At the same time, the number of series B and C deals have been stable, with more than 30 percent increase in investment value.8 This suggests that VCs are more inclined to follow up on previous investments (Exhibit 2).

Market activity in the United Kingdom began recovering in 2024, with an approximately 8 percent increase compared with 2023.
Image description: A stacked bar chart depicts total UK insurtech venture capital deals by stage from 2019 to 2024. Excluding the “other” category (which is without venture capital round classification), seed, pre-seed, and Series A deals have the highest share throughout the 2019–24 period, from 10 to 32 total deals. Series B and C deals number between 2 and 5 deals, and Series D and beyond occurred only in 2021 (with 2 deals) and 2023 (with 1 deal. Between 2020 and 2024, total deals decreased by 29%; seed, pre-seed, and Series A deals decreased by 41%; and Series B and C deals decreased by 25%. Another stacked bar chart also depicts invested capital in venture capital deals for different stages. Invested capital peaked in 2021, with £891 million, but fell to £206 million in 2023. Invested capital then grew 8% in 2024, to £223 million. Between 2020 and 2024, total invested capital had a CAGR of negative 3%; seed, pre-seed, and Series A had a CAGR of negative 15%; and Series B and C had a CAGR of positive 1%. Source: PitchBook End image description

UK insurtechs are accelerating international expansion

There has been increase in UK insurtechs expanding outward, with about 60 percent of UK insurtechs expanding internationally, up from about 50 percent in 2022. The majority of expanding insurtechs in the United Kingdom (also about 60 percent) have chosen Europe for their expansion, which is significantly higher than in 2023, when Australia and United States were the most popular.9 This is likely due to market saturation and higher cost to enter the Anglosphere (Exhibit 3).

About 60 percent of UK firms are expanding internationally, with further potential to expand in Asia and globally.
Image description: Bar charts show the share of UK insurtech firms that expanded internationally and the share of UK firms with an international base that entered different global regions. In 2025, 62% of UK insurtechs expanded internationally, 10 percentage points more than in 2023. 62% of international UK firms entered Europe, 46% entered the Anglosphere, 8% entered Asia, and 8% entered other parts of the world. Note: n = 20 insurtechs. Source: McKinsey UK Insurtech Survey, March 2023 (n = 30); McKinsey UK Insurtech Survey, March 2025 (n = 21) End image description

When choosing a new market to enter, insurtechs reported their most important considerations were customer preferences and regulation, previous founder experience, market competitiveness, and investment opportunities.10

Attention is shifting toward value chain enablers

Since 2018, the biggest funding rounds in the United Kingdom have been mostly evenly distributed among all insurtech archetypes, although interest is shifting from full-spectrum insurance entities using technology to improve their services to value chain enablers, or technology providers for insurers (see sidebar “What are value chain enablers?”). In the United Kingdom today, insurance entities make up about 25 percent of the insurtech population and value chain enablers make up 75 percent.

Only about 9 percent of funding targeted insurance entities in 2024, down from 75 percent in 2021. By contrast, since 2022, funding for value chain enablers has grown by 6 to 8 percent (although value chain enablers have smaller average deal sizes of £74 million versus £160 million for insurance entities). Claims-related and tech solution–related value chain enablers (about 15 percent and 13 percent, respectively) have attracted most of this growth (Exhibit 4).

Total funding for insurtechs has shifted away from insurance entities.
Image description: Waterfall charts show total funding per insurtech subtype for 2021 and 2024, in addition to 2021–24 CAGR. For insurance entities, such as property and casualty (including personal and commercial lines and small and medium-size enterprises) and life and health, funding was much higher in 2021 compared with 2024, making up 75% of total funding in 2021 and only 9% of total funding in 2024. Conversely, for value chain enablers, such as marketing and distribution, pricing and underwriting, claims, and tech solutions, funding made up only 25% of the total in 2021 and 91% in 2024. In total, 2021 funding was £912 million and 2024 funding was £251 million, with a CAGR of negative 35%. Note: Total funding includes venture capital, private equity, individual, corporate, and public funding. Insurance entities also include insurers, carriers, and managing general agents and managing general underwriters. End image description

Investors may be more attracted to value chain enablers due to a reduced appetite to back insurance businesses with balance sheet exposure, as well as greater market opportunities for carriers to modernize their tech stacks at faster and at lower costs with gen AI. This move toward value chain enablers would also not be possible without a growth in partnerships. Partnerships with incumbents help insurtechs access capacity, funding, and big data, while incumbents benefit from insurtechs’ state-of-the-art technology and talent, especially in niche markets.

Companies are innovating in response to evolving risks

According to our survey, insurance innovation is focused on new and emerging risks, specifically cyber, climate, and beyond-standard health insurance, although about three out of four insurtechs still focus on traditional risks and lines of business:

  • Cyber: Compared with the United Kingdom, cyber insurance has a deeper penetration rate in the United States (about 25 percent versus about 10 percent in the United Kingdom) and a larger average premium per policy ($4,000 versus $2,700), indicating room for growth.11
  • Climate: Climate-related insurance has experienced increasing demand due to intensifying weather extremes. The number of climate-related insurtechs based in the United Kingdom has increased by about 50 percent since 2019, and about 30 percent of polled managing general agents (MGAs) work with incumbents to deal with increasingly complex climate risks.12
  • Beyond-standard health insurance: UK insurtechs focusing on beyond-standard health insurance—for example, products offering improved coverage for certain conditions, such as fertility, and new channels of healthcare delivery, such as remote healthcare—have seen a 17 percent increase since 2022.13

In each of these areas, new products and technologies are expected to be the biggest opportunities (about 25 percent of respondents), and customer acquisition is expected to be the biggest challenge (about 20 percent of respondents) (Exhibit 5).

Insurance innovation is evolving around new and emerging risks to drive growth.
Image description: A pie chart shows UK insurtech entities by focus on lines of business. While 75% are still focused on traditional risks and lines of business, about 5% are focused on cyber, about 10% are focused on climate, and another approximate 10% are focused on health. For cyber, as AI-powered threats escalate and supply chains become key attack vectors, insurers are confronting mounting losses, unclear liabilities, and a cyber landscape evolving faster than traditional models can keep up. For climate, as extreme weather intensifies and disasters grow more frequent, insurers are grappling with soaring claims, shifting risk zones, and the growing unpredictability of climate volatility. And for health, as populations age, fertility declines, and healthcare goes digital, insurers face a triple threat of rising costs, shifting risk pools, and new vulnerabilities in remote care. Note: Insurtech entities are insurtech players that are either distributors, managing general agents and managing general underwriters, or carriers (excluding value chain enablers). The sample is based on 300 UK insurtech players. Source: Market.us; McKinsey Global Insurance Pool End image description

Gen AI is making waves in the UK insurtech industry

According to the survey, more than 70 percent of UK insurtech firms are already running or moving beyond gen AI pilot projects—well above the industry average of 40 percent adoption14—and more than 90 percent expecting to have gen AI in production in the next 12 months. Accordingly, developing and deploying new technologies with gen AI was the second-highest ranked opportunity identified by respondents, growing to almost 20 percent from about 10 percent in 2022.

Insurtechs are using gen AI for a number of purposes, including synthesizing and summarizing unstructured data,15 automating tedious human tasks, and otherwise augmenting human productivity. In insurance, gen AI is expected to have the biggest impact in claims-related tasks, enabling 20 to 25 percent cost savings by reducing the time spent processing claims. Improvements from gen AI are also expected in marketing and distribution (5 to 15 percent cost savings by reducing time spent on outreach and calls), pricing and underwriting (10 to 15 percent cost savings by reducing time spent on processing), and tech solutions (5 to 10 percent cost savings by reducing time spent on coding work and support tasks).16 Many of these opportunities are not yet realized: Although more than one-third of insurtechs are moving beyond pilots, only about 10 percent are attempting a full domain reimagination based on gen AI.17 Insurtechs that fully scale AI into their business models may gain an advantage (Exhibit 6).18

More than 90 percent of UK insurtech firms expect to have gen AI pilots in production by 2026.
Image description: Pie charts depict UK insurtech stages of the gen AI journey and insurtech expectations for gen AI pilots in production. 38% of UK insurtechs are running pilot projects, 9% are deploying or are fully operational in certain areas, 24% are scaling across multiple business functions, 24% are exploring possible use cases or other, and only 5% are not considering gen AI adoption at all. 46% of UK insurtechs expect to have gen AI pilots in production in the next 0 to 5 months, another 46% expect to do so in the next 6 to 11 months, and 8% expect gen AI pilots in production in the next 1 to 2 years. Source: McKinsey UK Insurtech Survey, March 2025 (n = 21) End image description

Insurtechs are focusing on costs, margins, and operational metrics

Because market conditions have shifted since 2023, when the most monitored factors among insurtechs were still growth, margins, and profitability, about 40 percent of UK insurtechs have adjusted their KPIs.19 In 2025, more insurtechs reported intending to focus on cost (57 percent versus 29 percent in 2023) and operational metrics (29 percent versus 19 percent in 2023), as opposed to product and customer metrics (Exhibit 7).

Our survey suggests insurtechs are shifting KPIs away from customer outcomes and product metrics and toward growth and costs.
Image description: A table shows top areas of focus for different metrics and the change in share of insurtech players that are focusing KPIs in a given area. For growth, top areas of focus are revenue or annual recurring revenue and sales. The share of insurtechs are focusing KPIs toward growth has grown by 18 percentage points. For product and customer metrics, top areas of focus are monthly active users and loss ratio. The share of insurtechs focusing KPIs in these metrics has fallen by 4 percentage points. For cost, margin, and cash flow, the top areas of focus are expense ratio or combined operating ratio profit and customer acquisition costs. The share of insurtechs focusing KPIs toward these metrics has grown by 28 percentage points. Last, for operational metrics, data quality is the top area of focus, and the share of insurtechs focusing KPIs toward these operational metrics has grown by 10 percentage points. End image description

These more tangible metrics include premiums and gross written premiums, monthly active users, and profit. Operationally, there has also been a move away from speed to market and toward data quality and cost reduction.

Some capabilities are core to success

To continue developing the industry and attracting funding, three elements will continue to be core to UK insurtechs’ success: prosperous partnerships, pioneering innovation, and trailblazing tech adoption:

  • Prosperous partnerships: Insurtechs are shifting from direct competition with incumbents to partnerships to leverage their capacity and data access. Partnerships are present today with MGAs, managing general underwriters, and value chain enablers, and looking forward, partnerships with incumbents will remain vital for insurtechs.
  • Pioneering product innovation: Insurtechs are uniquely able to explore niche markets and new product development, driven by their entrepreneurship and agility. MGAs working with incumbents navigating fast-growing areas (such as increasingly complex climate-related risks, cyber risks, and beyond-standard health insurance) can innovate rapidly to develop powerful new solutions.
  • Trailblazing tech adoption: The global insurtech industry has always been at the forefront of adopting new technologies across the value chain, such as machine learning pricing models and state-of-the-art technology platforms, the latest being gen AI. Maintaining their competitive advantage, agility, and innovative spirit by adopting new technology is essential for sustaining insurtech’s success as well as driving industry-wide growth.

The UK insurtech landscape stands out on the global stage as a center of innovation and collaboration. As the funding environment shifts and new technologies open up possibilities, UK insurtechs that stay on the ball can uphold their reputation as industry leaders and set themselves up to succeed in the years to come.

Explore a career with us